Warfarin vs. Aspirin in Reduced Cardiac Ejection Fraction (WARCEF)

ID Number 02-0536

Principal Investigator(s)
Bruce J Darrow

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


The purpose of this study is to determine which of two treatments, Warfarin or aspirin, is better for preventing death and stroke in patients with poor heart function. ClinicalTrials.gov Identifier: NCT00041938

Contact Information
Shamaelah Javed

Recruiting Patients: No